Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumour and normal tissue radiosensitivity.
Lapierre A, Gourgou S, Brengues M, Quéro L, Deutsch É, Milliat F, Riou O, Azria D. Lapierre A, et al. Among authors: gourgou s. Cancer Radiother. 2022 Feb-Apr;26(1-2):96-103. doi: 10.1016/j.canrad.2021.11.008. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953704
Letrozole sensitizes breast cancer cells to ionizing radiation.
Azria D, Larbouret C, Cunat S, Ozsahin M, Gourgou S, Martineau P, Evans DB, Romieu G, Pujol P, Pèlegrin A. Azria D, et al. Among authors: gourgou s. Breast Cancer Res. 2005;7(1):R156-63. doi: 10.1186/bcr969. Epub 2004 Dec 7. Breast Cancer Res. 2005. PMID: 15642164 Free PMC article.
Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P, Laliberte B, Allaw A, Ailleres N, Idri K, Hay MH, Moscardo CL, Gourgou S, Dubois JB, Azria D. Fenoglietto P, et al. Among authors: gourgou s. Radiother Oncol. 2008 Jul;88(1):77-87. doi: 10.1016/j.radonc.2007.12.011. Epub 2008 Jan 22. Radiother Oncol. 2008. PMID: 18215434
Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
Azria D, Belkacemi Y, Romieu G, Gourgou S, Gutowski M, Zaman K, Moscardo CL, Lemanski C, Coelho M, Rosenstein B, Fenoglietto P, Crompton NE, Ozsahin M. Azria D, et al. Among authors: gourgou s. Lancet Oncol. 2010 Mar;11(3):258-65. doi: 10.1016/S1470-2045(10)70013-9. Epub 2010 Feb 6. Lancet Oncol. 2010. PMID: 20138810 Clinical Trial.
111 results